NOVANTA INC
About NOVANTA INC
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
American Credentials
Each credential is independently reviewed before it’s awarded · last reviewed Jun 9, 2026. How this is verified →
Financial summary
- Revenue FY2025
- $980.6M
- Net income
- $53.8M
- Total assets
- $1.8B
- Market cap
- $5.6B
- Gross margin
- 44.4%
- Operating margin
- 9.6%
- Net margin
- 5.5%
Source: SEC EDGAR · updated Jun 8, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $980.6M
- Cost of revenue
- $545.3M
- Gross profit
- $435.3M
- Operating expenses
- $341.3M
- Operating income
- $94.0M
- Income tax
- $15.8M
- Net income
- $53.8M
- EPS (basic)
- $1.47
- EPS (diluted)
- $1.47
Balance sheet
- Total assets
- $1.8B
- Current assets
- $782.6M
- Total liabilities
- $492.8M
- Current liabilities
- $212.4M
- Shareholders’ equity
- $1.3B
Cash flow
- Operating cash flow
- $64.1M
- Investing cash flow
- -$74.3M
- Financing cash flow
- $276.3M
- Net cash flow
- $266.1M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $5.6B
- P/E ratio
- 111.8
- EPS (diluted)
- $1.47
- Shares outstanding
- 33.9M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Mar 24, 1999
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Profitable — net income of $53.8M in FY2025.
- Revenue grew 39% from FY2021 to FY2025.
- Gross margin of 44.4%, net margin 5.5%.
- Trading near its 52-week high.
- Valued at a price-to-earnings (P/E) ratio of 111.8.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review NOVANTA INC.
Write a review
News about NOVANTA INC
News & sentiment via Polygon.io
